Melissa de los Reyes is an experienced professional in the field of oncology and translational medicine, currently serving as the Tumour Portfolio Director for OBU Medical Affairs at AstraZeneca since March 2019. Previous roles at AstraZeneca include Director of Translational Medicine and Associate Director of Project Management in Early Oncology. Prior to AstraZeneca, Melissa worked at MedImmune as a Project Manager/Scientist and held positions in clinical biomarker development at LabCorp Clinical Trials and Covance. Additional experience includes laboratory management at Seattle Children's Hospital and roles as an associate scientist and senior research associate at MedImmune and Millennium Pharmaceuticals, respectively. Melissa holds a Master of Science in Biotechnology from The Johns Hopkins University and a Bachelor of Science in Molecular Biology from the University of Maryland.
Sign up to view 0 direct reports
Get started